financetom
Business
financetom
/
Business
/
--Amazon's Zoox Gets Regulatory Approval for Paid Robotaxis, Reuters Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Amazon's Zoox Gets Regulatory Approval for Paid Robotaxis, Reuters Reports
Jul 30, 2026 10:21 AM

12:44 PM EDT, 07/30/2026 (MT Newswires) --

Price: 238.66, Change: +12.01, Percent Change: +5.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
USITC says Russian palladium does not harm America cos, ends probe
USITC says Russian palladium does not harm America cos, ends probe
May 29, 2026
WASHINGTON, May 29 (Reuters) - Russian unwrought palladium, a metal used to reduce emissions in gasoline vehicles, does not injure American companies, the U.S. International Trade Commission said on Friday, ending Washington's anti-dumping investigation. The United States had been probing whether dumped or subsidized palladium from Russia harmed the U.S. industry, with the U.S. Department of Commerce last weekseparately deciding...
Market Chatter: Nikon Eyes Lithography Comeback With Price Play Against ASML
Market Chatter: Nikon Eyes Lithography Comeback With Price Play Against ASML
May 29, 2026
03:01 PM EDT, 05/29/2026 (MT Newswires) -- Nikon is pushing to reclaim ground in the semiconductor photolithography equipment market by undercutting Dutch rival ASML ( ASML ) on price, Nikkei Asia reported Friday, citing the Japanese company's president and chief executive, Yasuhiro Ohmura. Nikon produces many components in-house, giving it a structural cost advantage, Ohmura told Nikkei. The company is...
Johnson & Johnson Says Lung Cancer Study on Rybrevant Plus Lazcluze Suggests Potential for More Durable Disease Control
Johnson & Johnson Says Lung Cancer Study on Rybrevant Plus Lazcluze Suggests Potential for More Durable Disease Control
May 29, 2026
03:05 PM EDT, 05/29/2026 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that updated Phase 1/1b CHRYSALIS-2 data showed Rybrevant plus Lazcluze achieved a median overall survival of 41 months in patients with advanced non-small cell lung cancer with atypical epidermal growth factor receptor mutations. The company said the results add to the evidence showing potential of...
AGNC Investment Launches $2 Billion At-The-Market Offering
AGNC Investment Launches $2 Billion At-The-Market Offering
May 29, 2026
03:01 PM EDT, 05/29/2026 (MT Newswires) -- AGNC Investment ( AGNC ) announced Friday an at-the-market offering program to sell up to $2 billion of its common stock from time to time. Shares fell around 1.2% in recent trading. Price: 10.43, Change: -0.12, Percent Change: -1.14 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved